NAVIGATING THE FUTURE OF MEDICAL INNOVATION Trademark

Trademark Overview


On Thursday, February 5, 2015, a trademark application was filed for NAVIGATING THE FUTURE OF MEDICAL INNOVATION with the United States Patent and Trademark Office. The USPTO has given the NAVIGATING THE FUTURE OF MEDICAL INNOVATION trademark a serial number of 86525453. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, October 30, 2021. This trademark is owned by Pharmagellan, LLC. The NAVIGATING THE FUTURE OF MEDICAL INNOVATION trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management and consultation; Business management and consultation in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare.; Business management consulting, strategic planning and business advisory services provided to companies and innovators in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare
navigating the future of medical innovation

General Information


Serial Number86525453
Word MarkNAVIGATING THE FUTURE OF MEDICAL INNOVATION
Filing DateThursday, February 5, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, October 30, 2021
Registration Number4808292
Registration DateTuesday, September 8, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements


Goods and ServicesBusiness management and consultation; Business management and consultation in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare.; Business management consulting, strategic planning and business advisory services provided to companies and innovators in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare
NOT AVAILABLE"MEDICAL INNOVATION"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, February 19, 2015
Primary Code035
First Use Anywhere DateSunday, December 8, 2013
First Use In Commerce DateSunday, December 8, 2013

Trademark Owner History


Party NamePharmagellan, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481

Party NamePharmagellan, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481

Party NamePharmagellan, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481

Trademark Events


Event DateEvent Description
Monday, February 9, 2015NEW APPLICATION ENTERED
Tuesday, May 12, 2015ASSIGNED TO EXAMINER
Tuesday, September 8, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, February 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 12, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 8, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS SECTION 8 & 15 RECEIVED
Saturday, October 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, October 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, September 8, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 13, 2024TEAS SECTION 8 & 9 RECEIVED